If Al knows Afrezza is going to be approved and acheive blockbuster sales status, why would he want to discourage shorts? Wouldn't it be more devastating to facilitate large short positions until the PPS doubles on partner news, then doubles again on FDA approval? Seems to me that is better letting them off the hook in the mid 5's.